ZOTA · Health Care · 2026-08-21

Zota Health Care Ltd

Stage 1 · wk 11In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹1,087.4
+0.99% today
₹3,298 Cr · Small cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores under the DAVAINDIA name. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India.

Visit company website →
ROE
-16.0%
Profit margin -13.7%
Dividend Yield
0.09%
P/B 10.9
vs 52W High
-35.5%
₹1,043.1 lo₹1,687 hi
35.5% below 52W high — far from high
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 11
1w13w26w
Week 11 — base building
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
-18.7%
200 DMA: ₹1,337.5 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.74x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↓
MA20 rolling over · -6.8% vs MA50 +0.8%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
Sector has 84 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
↑ Building
Stage 2%
56.1%
20d Δ
+5.6pp
1M return
+2.7%
3M return
+10.4%
Industry Stage-2 % · last 20 days
Industry has 58 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-26 → 2026-08-21
S2 16w
S2 23w
S2 19w
S2 34w
2023-05-262026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 3w → S1 1w → S2 16w → S3 8w → S2 23w → S3 5w → S2 19w → S3 8w → S2 13w → S3 8w → S2 34w → S3 8w → S4 13w → S1 10w current
Total tracked: 168 weeks across 14 stage runs.
1M
-16.1%
3M
-8.8%
6M
-21.0%
YTD
-29.2%
1Y
-18.3%
Scan Membership
Breakout Watch
Latest: 2025-05-22
3 appearances in last 60 days. First seen: 2024-06-14.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S1
Wk 11 · Vol —x
2026-08-20S1
Wk 11 · Vol —x
2026-08-19S1
Wk 10 · Vol —x
2026-08-18S1
Wk 10 · Vol —x
2026-08-17S1
Wk 10 · Vol —x
2026-08-14S1
Wk 10 · Vol —x
2026-08-13S1
Wk 10 · Vol —x
2026-08-12S1
Wk 9 · Vol —x
2026-08-11S1
Wk 9 · Vol —x
2026-08-10S1
Wk 9 · Vol —x
2026-08-07S1
Wk 9 · Vol —x
2026-08-06S1
Wk 9 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹1,296.9
200 DMA
₹1,337.5
52W High
₹1,687
52W Low
₹1,043.1
5D Low
₹1,076.7
Resistance levels (recent highs)
20d High
₹1,283.1
60d High
₹1,444.9
120d High
₹1,444.9
250d High
₹1,687
Next resistance
+18.0%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.